Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs

Jingyin Yue1, Fan Lai1, Felipe Beckedorff1

  • 1Department of Human Genetics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

Genes & Development
|October 7, 2017
PubMed

Insights

Integrator, a key complex in cellular signaling, acts downstream of the RAS-MEK-extracellular signal-related kinase (ERK1/2) pathway. Its depletion reduces cancer cell growth, suggesting Integrator as a potential therapeutic target for MAPK-driven cancers.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Gene Regulation

Background:

  • Activating mutations in the mitogen-activated protein kinase (MAPK) cascade drive over 70% of human cancers.
  • While MAPK pathway components are well-studied, downstream transcriptional coactivators remain less understood.

Purpose of the Study:

  • To identify and characterize the key downstream coactivators coordinating the transcriptional response in the MAPK signaling pathway.
  • To investigate the role of the Integrator complex in MAPK-driven transcriptional regulation and cancer growth.

Main Methods:

  • Depletion of Integrator complex subunits using knockdown techniques.
  • Pharmacological inhibition of the MAPK pathway.
  • Analysis of gene expression changes and protein phosphorylation following epidermal growth factor (EGF) stimulation.
  • Comparison with the effects of Mediator complex subunit depletion.

Main Results:

  • Integrator depletion significantly reduces ERK1/2 transcriptional responsiveness and cancer cell growth in MAPK-mutated cancers.
  • Activated ERK1/2 phosphorylates INTS11, the Integrator catalytic subunit, upon EGF stimulation.
  • Integrator recruitment to immediate early genes and enhancers is abrogated by MAPK pathway inhibition.
  • Integrator depletion impacts MAPK-responsive genes more broadly than Mediator subunit depletion.

Conclusions:

  • The Integrator complex is a crucial transcriptional coactivator in the MAPK signaling pathway.
  • Integrator plays a significant role in the growth of human cancers with activating MAPK mutations, including those resistant to targeted therapies.
  • Integrator represents a promising downstream therapeutic target for treating MAPK-driven cancers.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.2K